Difference between revisions of "Part:BBa K4035001:Design"
(→Design Notes) |
|||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | The start and stop codon of the CUP1 genomic sequence were removed before | + | The start and stop codon of the CUP1 genomic sequence were removed before insertion in the plasmid in order to fuse the protein to Aga2 and V5. |
===Source=== | ===Source=== | ||
− | The CUP1 ([https://parts.igem.org/Part:BBa_M45090 BBa_M45090]) sequence is the genomic sequence of the copper | + | The CUP1 ([https://parts.igem.org/Part:BBa_M45090 BBa_M45090]) sequence is the genomic sequence of the copper metallothionein 1 protein and was inserted in the pCTcon2-V5 plasmid that was already containing Aga2, V5 tag and the Gal1 promoter. |
===References=== | ===References=== | ||
(1) Chao, G.; Lau, W. L.; Hackel, B. J.; Sazinsky, S. L.; Lippow, S. M.; Wittrup, K. D. Isolating and Engineering Human Antibodies Using Yeast Surface Display. Nat Protoc 2006, 1 (2), 755–768. https://doi.org/10.1038/nprot.2006.94. | (1) Chao, G.; Lau, W. L.; Hackel, B. J.; Sazinsky, S. L.; Lippow, S. M.; Wittrup, K. D. Isolating and Engineering Human Antibodies Using Yeast Surface Display. Nat Protoc 2006, 1 (2), 755–768. https://doi.org/10.1038/nprot.2006.94. |
Revision as of 19:00, 21 October 2021
CUP1 fused to Aga2 and tagged with a V5 epitope
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 319
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 376
Illegal PstI site found at 319 - 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 562
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 319
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 319
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
The start and stop codon of the CUP1 genomic sequence were removed before insertion in the plasmid in order to fuse the protein to Aga2 and V5.
Source
The CUP1 (BBa_M45090) sequence is the genomic sequence of the copper metallothionein 1 protein and was inserted in the pCTcon2-V5 plasmid that was already containing Aga2, V5 tag and the Gal1 promoter.
References
(1) Chao, G.; Lau, W. L.; Hackel, B. J.; Sazinsky, S. L.; Lippow, S. M.; Wittrup, K. D. Isolating and Engineering Human Antibodies Using Yeast Surface Display. Nat Protoc 2006, 1 (2), 755–768. https://doi.org/10.1038/nprot.2006.94.